Mariner
JAZZ icon

Mariner’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mariner’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.56M Buy
40,016
+14,675
+58% +$2.56M 0.01% 871
2025
Q4 		$4.31M Buy
25,341
+5,066
+25% +$777K 0.01% 1071
2025
Q3 		$2.67M Buy
20,275
+1,583
+8% +$190K ﹤0.01% 1258
2025
Q2 		$1.98M Sell
18,692
-8,268
-31% -$898K ﹤0.01% 1338
2025
Q1 		$3.35M Buy
26,960
+157
+0.6% +$20.5K 0.01% 970
2024
Q4 		$3.3M Buy
26,803
+6,782
+34% +$799K 0.01% 971
2024
Q3 		$2.23M Buy
20,021
+1,309
+7% +$143K ﹤0.01% 1136
2024
Q2 		$2M Buy
18,712
+10,642
+132% +$1.17M ﹤0.01% 1110
2024
Q1 		$972K Buy
8,070
+1,767
+28% +$216K ﹤0.01% 1517
2023
Q4 		$775K Sell
6,303
-1,734
-22% -$216K ﹤0.01% 1620
2023
Q3 		$1.04M Buy
8,037
+757
+10% +$101K ﹤0.01% 1296
2023
Q2 		$902K Buy
7,280
+262
+4% +$35.3K ﹤0.01% 1369
2023
Q1 		$1.03M Buy
7,018
+813
+13% +$120K ﹤0.01% 1256
2022
Q4 		$988K Buy
6,205
+505
+9% +$74K ﹤0.01% 1248
2022
Q3 		$760K Buy
+5,700
New +$867K ﹤0.01% 1189
2019
Q3 		– Sell
-1,673
Closed -$239K – 874
2019
Q2 		$239K Buy
1,673
+19
+1% +$2.55K ﹤0.01% 973
2019
Q1 		$236K Buy
+1,654
New +$216K ﹤0.01% 904
2017
Q1 		– Sell
-2,447
Closed -$267K – 603
2016
Q4 		$267K Buy
+2,447
New +$273K 0.01% 469

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Mariner's JAZZ Position: Q1 2026 in Review

Mariner increased its Jazz Pharmaceuticals (JAZZ) stake by 58% in Q1 2026, buying an estimated $2.56M and bringing the position to 40,016 shares worth $7.56M. The position accounts for 0.01% of the portfolio, ranked #871.

Mariner first reported a position in JAZZ in Q4 2016 and has held it in 18 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Mariner held 40,016 shares of Jazz Pharmaceuticals worth $7.56M as of Q1 2026.
  • Mariner bought 14,675 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.56M.
  • Jazz Pharmaceuticals made up 0.01% of Mariner's portfolio in Q1 2026, its #871 holding.
  • Mariner first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 18 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.